PEPT (Regenerex Pharma) Total Stockholders Equity : $-4.31 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerex Pharma Total Stockholders Equity?

Regenerex Pharma's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $-4.31 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Regenerex Pharma's Book Value per Share for the quarter that ended in Jun. 2024 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Regenerex Pharma's Debt-to-Equity for the quarter that ended in Jun. 2024 was -0.96.

Regenerex Pharma Total Stockholders Equity Historical Data

The historical data trend for Regenerex Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerex Pharma Total Stockholders Equity Chart

Regenerex Pharma Annual Data

Trend

Nov10

Nov11

Nov12

Nov13

Nov14

Mar17

Mar18

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

-0.28

-0.32

-0.99

-1.12

-4.06

Regenerex Pharma Quarterly Data
	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial															-1.08	-3.63	-3.88	-4.06	-4.31

Regenerex Pharma (OTCPK:PEPT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Regenerex Pharma's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-4.313	-	0)	/	278.226
	=	-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Regenerex Pharma's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.532	+	0.629)	/	-4.313
	=	-0.96

Regenerex Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Regenerex Pharma Inc (OTCPK:PEPT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Suite 177, Las Vegas, NV, USA, 89108

Website

https://regenerexpharmainc.com

Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the Company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.

Regenerex Pharma Headlines

No Headlines